To highlight concerns regarding the generalizability of findings from Mokrani et al.’s study on antibiotic regimens for difficult-to-treat Stenotrophomonas maltophilia ICU-acquired pneumonia due to limitations in the study's design.
Approach:
Sampling Frame Concerns: The study's case ascertainment relied on microbiology database searches, potentially omitting clinically diagnosed cases with negative cultures.
Denominator Problem Implications: The case mix may favor patients with higher bacterial burden, affecting outcome interpretations and limiting guidance for culture-negative cases.
MIC Data Generalizability: Concerns about the generalizability of reported MIC data due to variability in susceptibility testing methods and missing information.
Key Findings:
Clinically diagnosed DTR S. maltophilia pneumonia with negative cultures was omitted from the study.
The cohort may represent a selection effect rather than the natural history of the infection.
Quantitative MIC data were limited and varied across testing methods, affecting drug classification.
Interpretation:
The findings should be limited to microbiologically confirmed DTR S. maltophilia pneumonia, as culture-negative cases may have different prognostic characteristics, necessitating caution in applying these results.
Limitations:
Omission of culture-negative cases may skew understanding of the infection's natural history and limit the applicability of findings.
Variability in susceptibility testing methods could influence drug classification and outcomes.
Conclusion:
Future studies should explore differences in prognosis and treatment for culture-negative cases and standardize susceptibility testing to address the identified gaps.
